دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Breast cancer screening: one size does not fit all
doi : 10.1016/S1470-2045(23)00590-9
Volume 24, Issue 12, December 2023, Page 1287
An HPV vaccine from India: broadening possibilities for cervical cancer control
John T Schiller, Aimée R Kreimer
doi : 10.1016/S1470-2045(23)00535-1
Volume 24, Issue 12, December 2023, Pages 1288-1289
The challenge of improving outcomes in locally advanced cervical cancer
Linda R Mileshkin
doi : 10.1016/S1470-2045(23)00532-6
Volume 24, Issue 12, December 2023, Pages 1289-1291
Non-invasive DNA methylation-based testing for the diagnosis of endometrial cancer
Jessica St Laurent, *Kevin M Elias
doi : 10.1016/S1470-2045(23)00522-3
Volume 24, Issue 12, December 2023, Pages 1291-1292
Drug development for hepatocellular carcinoma
Landon L Chan, *Stephen L Chan
doi : 10.1016/S1470-2045(23)00523-5
Volume 24, Issue 12, December 2023, Pages 1292-1294
Long-term efficacy of ibrutinib–venetoclax for first-line treatment in chronic lymphocytic leukaemia
Anna Fink
doi : 10.1016/S1470-2045(23)00485-0
Volume 24, Issue 12, December 2023, Pages 1294-1295
Global cancer surgery: a vital service to eliminate false economy
Allison Landman, David Collingridge
doi : 10.1016/S1470-2045(23)00533-8
Volume 24, Issue 12, December 2023, Pages 1296-1297
Cancer surgery: orchestrating cancer control by strengthening health systems
*Mary Gospodarowicz, Anna Dare, David A Jaffray
doi : 10.1016/S1470-2045(23)00484-9
Volume 24, Issue 12, December 2023, Pages 1297-1298
The pathway for surgery as an integral part of attaining universal health coverage
*Bente Mikkelsen, Raffaella Casolino
doi : 10.1016/S1470-2045(23)00566-1
Volume 24, Issue 12, December 2023, Pages 1298-1301
Improving access to surgery for childhood cancer
Lars Hagander
doi : 10.1016/S1470-2045(23)00477-1
Volume 24, Issue 12, December 2023, Pages 1301-1302
Investing in gender equality and equitable access improves outcomes
*Nazik Hammad, Ophira Ginsburg
doi : 10.1016/S1470-2045(23)00521-1
Volume 24, Issue 12, December 2023, Pages 1302-1304
A new generation of comprehensive precision oncology trials
Birgit Geoerger, Francisco Bautista, Susanne A Gatz, Lynley V Marshall, Nicolas André
doi : 10.1016/S1470-2045(23)00476-X
Volume 24, Issue 12, December 2023, Page e452
Tumor Treating Fields therapy in metastatic non-small-cell lung cancer
Timothée Olivier, Alfredo Addeo
doi : 10.1016/S1470-2045(23)00474-6
Volume 24, Issue 12, December 2023, Page e453
Tumor Treating Fields therapy in metastatic non-small-cell lung cancer – Authors' reply
*Ticiana Leal, Corey Langer
doi : 10.1016/S1470-2045(23)00584-3
Volume 24, Issue 12, December 2023, Page e454
Combined cytotoxic and immune-stimulatory gene therapy for glioma
Binghao Zhao, Longping Yao, *Wenbin Ma
doi : 10.1016/S1470-2045(23)00507-7
Volume 24, Issue 12, December 2023, Page e455
Combined cytotoxic and immune-stimulatory gene therapy for glioma – Authors' reply
*Pedro R Lowenstein, Maria G Castro
doi : 10.1016/S1470-2045(23)00586-7
Volume 24, Issue 12, December 2023, Page e456
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
Bengü Mutlu Sütcüo?lu, *Osman Sütcüo?lu
doi : 10.1016/S1470-2045(23)00471-0
Volume 24, Issue 12, December 2023, Page e457
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer – Authors' reply
S Lot Aronson, Gabe S Sonke, *Willemien J van Driel
doi : 10.1016/S1470-2045(23)00588-0
Volume 24, Issue 12, December 2023, Page e458
Correction to Lancet Oncol 2023; 24: 107–16
doi : 10.1016/S1470-2045(23)00594-6
Volume 24, Issue 12, December 2023, Page e459
Correction to Lancet Oncol 2023; 24: 1219–28
doi : 10.1016/S1470-2045(23)00565-X
Volume 24, Issue 12, December 2023, Page e459
Correction to Lancet Oncol 2023; 24: 1359–74
doi : 10.1016/S1470-2045(23)00580-6
Volume 24, Issue 12, December 2023, Page e459
Correction to Lancet Oncol 2023; 24: e472–518
doi : 10.1016/S1470-2045(23)00585-5
Volume 24, Issue 12, December 2023, Page e459
Launch of the Latin America and the Caribbean Code Against Cancer
Talha Burki
doi : 10.1016/S1470-2045(23)00561-2
Volume 24, Issue 12, December 2023, Page 1305
New imPACT review in Papua New Guinea
Manjulika Das
doi : 10.1016/S1470-2045(23)00562-4
Volume 24, Issue 12, December 2023, Page 1306
ESMO Congress 2023
Jessica E Dwyer
doi : 10.1016/S1470-2045(23)00563-6
Volume 24, Issue 12, December 2023, Pages 1307-1308
IASLC calls for clinical trials to use tobacco use data
Bryant Furlow
doi : 10.1016/S1470-2045(23)00569-7
Volume 24, Issue 12, December 2023, Page 1309
Proposal to lower Australia's bowel screening age limit from 50 to 45 years
Tony Kirby
doi : 10.1016/S1470-2045(23)00570-3
Volume 24, Issue 12, December 2023, Page 1310
HPV vaccine roll-out in Nigeria and Bangladesh
Munyaradzi Makoni
doi : 10.1016/S1470-2045(23)00571-5
Volume 24, Issue 12, December 2023, Pages 1311-1312
Last cancer hospital in Gaza
Talha Burki
doi : 10.1016/S1470-2045(23)00581-8
Volume 24, Issue 12, December 2023, Page 1313
Cancer care in Nepal after earthquake
Manjulika Das
doi : 10.1016/S1470-2045(23)00582-X
Volume 24, Issue 12, December 2023, Page 1314
New junk food legislation in Colombia
Talha Burki
doi : 10.1016/S1470-2045(23)00591-0
Volume 24, Issue 12, December 2023, Page e460
Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine
Marta Salek, Alexandra Mueller, Inna Alanbousi, Zuzanna Cepowska, Malgorzata Dutkiewicz, Julian Earl, Dmitry Evseev, Roman Kizyma, Khrystyna Kliuchkivska, Julia Kolodrubiec, Katarzyna Matczak, Yuliya Nogovitsyna, Aleksandra Oszer, Mikhail Pogorelyy, Anna Raciborska, Suheir Rasul, Igor Sokolowski, Andriy Sopilnyak, Anna Vinitsky, Marcin W Wlodarski, Natalia Wobst, Taisiya Yakimkova, Carlos Rodriguez-Galindo, Paul H Wise, Wojciech Mlynarski, Asya Agulnik, on behalf of the SAFER Ukraine Collaborative
doi : 10.1016/S1470-2045(23)00456-4
Volume 24, Issue 12, December 2023, Pages 1315-1318
The ways we talk about cancer
Caroline A Kinsey
doi : 10.1016/S1470-2045(23)00443-6
Volume 24, Issue 12, December 2023, Pages 1318-1319
Art and hope for children with cancer
Fatemeh Ebrahimpour, *Jila Mirlashari
doi : 10.1016/S1470-2045(23)00574-0
Volume 24, Issue 12, December 2023, Pages 1319-1320
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Neerja Bhatla, Smita Joshi, Sharmila Pimple, Anand Kawade, Latha Balasubramani, Anitha Thomas, Vanita Suri, Sanjay Lalwani, Rajini Uday, Veena Kamath, Ranajit Mandal, A Rajeswar, Abraham Peedicayil, Usha Rani Poli, Dipanwita Banerjee, Rengaswamy Sankaranarayanan, Partha Basu, Richard Muwonge, Sunil Gairola, Vikas Dogar, Harish Rao, Umesh Shaligram
doi : 10.1016/S1470-2045(23)00480-1
Volume 24, Issue 12, December 2023, Pages 1321-1333
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
Bradley J Monk, Takafumi Toita, Xiaohua Wu, Juan C V?zquez Lim?n, Rafal Tarnawski, Masaki Mandai, Ronnie Shapira-Frommer, Umesh Mahantshetty, Maria del Pilar Estevez-Diz, Qi Zhou, Sewanti Limaye, Francisco J Ramirez Godinez, Christina Oppermann Kussler, Szilvia Varga, Natalia Valdiviezo, Daisuke Aoki, Manuel Leiva, Jung-Yun Lee, Raymond Sulay, Yulia Kreynina, Wen-Fang Cheng, Felipe Rey, Yi Rong, Guihao Ke, Sophie Wildsmith, Andrew Lloyd, Hannah Dry, Ana Tablante Nunes, Jyoti Mayadev
doi : 10.1016/S1470-2045(23)00479-5
Volume 24, Issue 12, December 2023, Pages 1334-1348
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study
Teska N Schuurman*, Mirte Schaafsma*, Kaylee H To, Viola M J Verhoef, Karolina Sikorska, Albert G Siebers, Hans H B Wenzel, Maaike C G Bleeker, Eva Maria Roes, Ronald P Zweemer, Peggy J de Vos van Steenwijk, Refika Yigit, Jogchum J Beltman, Petra L M Zusterzeel, Christianne A R Lok, Ruud L M Bekkers, Constantijne H Mom†, Nienke E van Trommelâ€
doi : 10.1016/S1470-2045(23)00467-9
Volume 24, Issue 12, December 2023, Pages 1349-1358
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial
Galina Velikova, James P Morden, Joanne S Haviland, Charlotte Emery, Peter Barrett-Lee, Helena Earl, David Bloomfield, Adrian Murray Brunt, Peter Canney, Robert Coleman, Mark Verrill, Andrew Wardley, Gianfilippo Bertelli, Paul Ellis, Rob Stein, Judith M Bliss, David Cameron, on behalf of the TACT2 Trial Management Group
doi : 10.1016/S1470-2045(23)00460-6
Volume 24, Issue 12, December 2023, Pages 1359-1374
Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK
Iona Evans*, Daniel Reisel*, Allison Jones*, Alba Bajrami*, Simrit Nijjar, Sarah Annie Solangon, Rupali Arora, Elisa Redl, Lena Schreiberhuber, Isma Ishaq-Parveen, Julia Roth?rmel, Chiara Herzog, Davor Jurkovic, Martin Widschwendter
doi : 10.1016/S1470-2045(23)00466-7
Volume 24, Issue 12, December 2023, Pages 1375-1386
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
Cullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, Manisha Palta, Brian Czito, Manoop S Bhutani, Lauren E Colbert, Joseph Abi Jaoude, Vincent Bernard, Shubham Pant, Ching-Wei D Tzeng, Dae Won Kim, Mokenge Malafa, James Costello, Geena Mathew, Neal Rebueno, Eugene J Koay, Prajnan Das, Ethan B Ludmir, Matthew H G Katz, Robert A Wolff, Sam Beddar, Gabriel O Sawakuchi, Shalini Moningi, Rebecca S Slack Tidwell, Ying Yuan, Peter F Thall, Robert A Beardsley, Jon Holmlund, Joseph M Herman, Sarah E Hoffe
doi : 10.1016/S1470-2045(23)00478-3
Volume 24, Issue 12, December 2023, Pages 1387-1398
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek-Yeol Ryoo, Zhenggang Ren, Gianluca Masi, Mariusz Kwiatkowski, Ho Yeong Lim, Jee Hyun Kim, Valeriy Breder, Hiromitsu Kumada, Ann-Lii Cheng, Peter R Galle, Shuichi Kaneko, Anran Wang, Kalgi Mody, Corina Dutcus, Leonid Dubrovsky, Abby B Siegel, Richard S Finn, for the LEAP-002 Investigators*
doi : 10.1016/S1470-2045(23)00469-2
Volume 24, Issue 12, December 2023, Pages 1399-1410
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Qinghe Zeng, Christophe Klein, Stefano Caruso, Pascale Maille, Daniela S Allende, Beatriz M?nguez, Massimo Iavarone, Massih Ningarhari, Andrea Casadei-Gardini, Federica Pedica, Margherita Rimini, Riccardo Perbellini, Camille Boulagnon-Rombi, Alexandra Heurgué, Marco Maggioni, Mohamed Rela, Mukul Vij, Sylvain Baulande, Patricia Legoix, Sonia Lameiras, the HCC-AI study group*, Léa Bruges, Viviane Gnemmi, Jean-Charles Nault, Claudia Campani, Hyungjin Rhee, Young Nyun Park, Mercedes I?arrairaegui, Guillermo Garcia-Porrero, Josepmaria Argemi, Bruno Sangro, Antonio D’Alessio, Bernhard Scheiner, David James Pinato, Matthias Pinter, Valérie Paradis, Aurélie Beaufrère, Simon Peter, Lorenza Rimassa, Luca Di Tommaso, Arndt Vogel, Sophie Michalak, Jérôme Boursier, Nicolas Loménie, Marianne Ziol, Julien Calderaro
doi : 10.1016/S1470-2045(23)00468-0
Volume 24, Issue 12, December 2023, Pages 1411-1422
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Carsten U Niemann, Talha Munir, Carol Moreno, Carolyn Owen, George A Follows, Ohad Benjamini, Ann Janssens, Mark-David Levin, Tadeusz Robak, Martin Simkovic, Sergey Voloshin, Vladimir Vorobyev, Munci Yagci, Loic Ysebaert, Keqin Qi, Qianya Qi, Pierre Sinet, Lori Parisi, Srimathi Srinivasan, Natasha Schuier, Kurt Baeten, Angela Howes, Donne Bennett Caces, Arnon P Kater
doi : 10.1016/S1470-2045(23)00452-7
Volume 24, Issue 12, December 2023, Pages 1423-1433
Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort
Cindy Im*, Zhe Lu*, Sogol Mostoufi-Moab, Angela Delaney, Lin Yu, Jessica L Baedke, Yutong Han, Yadav Sapkota, Yutaka Yasui, Eric J Chow, Rebecca M Howell, Smita Bhatia, Melissa M Hudson, Kirsten K Ness, Gregory T Armstrong, Paul C Nathan†, Yan Yuanâ€
doi : 10.1016/S1470-2045(23)00510-7
Volume 24, Issue 12, December 2023, Pages 1434-1442
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Reinhard Dummer*, Paola Queirolo*, Pauline Gerard Duhard, Youyou Hu, Dao Wang, Sergio Jobim de Azevedo, Caroline Robert, Paolo Antonio Ascierto, Vanna Chiarion-Sileni, Paolo Pronzato, Francesco Spagnolo, Karmele Mujika Eizmendi, Gabriella Liszkay, Luis de la Cruz Merino†, Hussein Tawbi
doi : 10.1016/S1470-2045(23)00334-0
Volume 24, Issue 12, December 2023, Pages e461-e471
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
Chandrakanth Are, Shilpa S Murthy, Richard Sullivan, Makayla Schissel, Sanjib Chowdhury, Olesegun Alatise, Daniel Anaya, Madhuri Are, Charles Balch, David Bartlett, Murray Brennan, Lydia Cairncross, Matthew Clark, S V S Deo, Vikas Dudeja, Domenico D’Ugo, Ibtihal Fadhil, Armando Giuliano, Satish Gopal, Lily Gutnik, Andre Ilbawi, Pankaj Jani, T Peter Kingham, Laura Lorenzon, Premila Leiphrakpam, Augusto Leon, Hector Martinez-Said, Kelly McMasters, David O Meltzer, Miriam Mutebi, Syed Nabeel Zafar, Vibhavari Naik, Lisa Newman, Alexandre Ferreira Oliveira, Do Joong Park, C S Pramesh, Saieesh Rao, T Subramanyeshwar Rao, Enrique Bargallo-Rocha, Anya Romanoff, Anne F Rositch, Isabel T Rubio, Heber Salvador de Castro Ribeiro, Eman Sbaity, Maheswari Senthil, Lynette Smith, Masakazi Toi, Kiran Turaga, Ujwal Yanala, Cheng-Har Yip, Ashraf Zaghloul, Benjamin O Anderson
doi : 10.1016/S1470-2045(23)00412-6
Volume 24, Issue 12, December 2023, Pages e472-e518
Pancytopenia associated with bone marrow infiltration from late relapse of neuroblastoma
Charles J Milrod*, Geoffrey Binney*, Muhammad Azeem Khan
doi : 10.1016/S1470-2045(23)00520-X
Volume 24, Issue 12, December 2023, Page e519
